Concepedia

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Xiaoying Shen, Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler, Hyejin Yoon, Dapeng Li, Barton F. Haynes, Kevin O. Sanders,

Cell Host & Microbe · 2021 · 395 citations · 54 references

DOIFull text

Open access

Concepts

References

54

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.5K citations · Full text

, , +17

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine · 2020 · 10.7K citations · Full text

, , +17

Statistical significance for genomewide studies

John D. Storey, Robert Tibshirani · Proceedings of the National Academy of Sciences · 2003 · 10.1K citations · Full text

, , +13

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Bulletin of Miscellaneous Information (Royal Gardens Kew) · 2020 · 7.3K citations

, , +17

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

, , +17